A publicly available database (human protein atlas: http: www.proteiatlas.org) showed that the high expression of TIPARP was associated with a poor prognosis in lung cancer; the 5 year survival rates in high and low expression cases were 38% and 47%, respectively (P = 0.036). Here, TIPARP is linked to lung carcinoma.